Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Ritonavir

Trial Locations (8)

12208

Albany Med College, Albany

21201

Chase Braxton Health Service, Baltimore

27599

Univ of North Carolina / Infectious Disease Division, Chapel Hill

33136

Univ of Miami School of Medicine, Miami

60611

Northwestern Univ / Div of Infect Diseases, Chicago

90033

LAC / USC Med Ctr / Infectious Diseases, Los Angeles

97210

The Research and Education Group, Portland

02215

Beth Israel Deaconess Med Ctr, Boston

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY